Namenda
February 6, 2004 by admin · Leave a Comment
In October of 2003, Forest Laboratories announced FDA approval of Namenda™ (memantine HCL) for moderate-to-severe Alzheimer’s disease. This new therapy is the first of a new class of drugs for Alzheimer’s disease known as NMDA antagonists. Namenda is thought to decrease the affinity of the NMDA receptor for a neurotransmitter known as glutamate, which plays [...]